Standard
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents. / Maeng, Michael; Tilsted, Hans-Henrik; Jensen, Lisette Okkels; Kaltoft, Anne Kjer; Kelbæk, Henning; Abildgaard, Ulrik; Villadsen, Anton B; Krusell, Lars Romer; Ravkilde, Jan; Hansen, Knud Nørregaard; Christiansen, Evald Høj; Aarøe, Jens; Jensen, Jan Skov; Kristensen, Steen Dalby; Bøtker, Hans Erik; Madsen, Morten; Thayssen, Per; Sørensen, Henrik Toft; Thuesen, Leif; Lassen, Jens Flensted.
In:
Circulation. Cardiovascular Interventions, Vol. 5, No. 8, 2012, p. 812-8.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Maeng, M, Tilsted, H-H, Jensen, LO, Kaltoft, AK, Kelbæk, H, Abildgaard, U, Villadsen, AB, Krusell, LR, Ravkilde, J, Hansen, KN, Christiansen, EH, Aarøe, J, Jensen, JS, Kristensen, SD, Bøtker, HE, Madsen, M, Thayssen, P, Sørensen, HT, Thuesen, L & Lassen, JF 2012, '
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents',
Circulation. Cardiovascular Interventions, vol. 5, no. 8, pp. 812-8.
https://doi.org/10.1016/j.jcin.2012.04.008APA
Maeng, M., Tilsted, H-H., Jensen, L. O., Kaltoft, A. K., Kelbæk, H., Abildgaard, U., Villadsen, A. B., Krusell, L. R., Ravkilde, J., Hansen, K. N., Christiansen, E. H., Aarøe, J., Jensen, J. S., Kristensen, S. D., Bøtker, H. E., Madsen, M., Thayssen, P., Sørensen, H. T., Thuesen, L., & Lassen, J. F. (2012).
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.
Circulation. Cardiovascular Interventions,
5(8), 812-8.
https://doi.org/10.1016/j.jcin.2012.04.008Vancouver
Maeng M, Tilsted H-H, Jensen LO, Kaltoft AK, Kelbæk H, Abildgaard U et al.
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.
Circulation. Cardiovascular Interventions. 2012;5(8):812-8.
https://doi.org/10.1016/j.jcin.2012.04.008Author
Maeng, Michael ; Tilsted, Hans-Henrik ; Jensen, Lisette Okkels ; Kaltoft, Anne Kjer ; Kelbæk, Henning ; Abildgaard, Ulrik ; Villadsen, Anton B ; Krusell, Lars Romer ; Ravkilde, Jan ; Hansen, Knud Nørregaard ; Christiansen, Evald Høj ; Aarøe, Jens ; Jensen, Jan Skov ; Kristensen, Steen Dalby ; Bøtker, Hans Erik ; Madsen, Morten ; Thayssen, Per ; Sørensen, Henrik Toft ; Thuesen, Leif ; Lassen, Jens Flensted. / 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents. In: Circulation. Cardiovascular Interventions. 2012 ; Vol. 5, No. 8. pp. 812-8.
Bibtex
@article{e990f9dc75ef4a8aa2b23511c980be07,
title = "3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents",
abstract = "This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.",
author = "Michael Maeng and Hans-Henrik Tilsted and Jensen, {Lisette Okkels} and Kaltoft, {Anne Kjer} and Henning Kelb{\ae}k and Ulrik Abildgaard and Villadsen, {Anton B} and Krusell, {Lars Romer} and Jan Ravkilde and Hansen, {Knud N{\o}rregaard} and Christiansen, {Evald H{\o}j} and Jens Aar{\o}e and Jensen, {Jan Skov} and Kristensen, {Steen Dalby} and B{\o}tker, {Hans Erik} and Morten Madsen and Per Thayssen and S{\o}rensen, {Henrik Toft} and Leif Thuesen and Lassen, {Jens Flensted}",
note = "Copyright {\textcopyright} 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.jcin.2012.04.008",
language = "English",
volume = "5",
pages = "812--8",
journal = "Circulation: Cardiovascular Interventions",
issn = "1941-7640",
publisher = "Lippincott Williams & Wilkins",
number = "8",
}
RIS
TY - JOUR
T1 - 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
AU - Maeng, Michael
AU - Tilsted, Hans-Henrik
AU - Jensen, Lisette Okkels
AU - Kaltoft, Anne Kjer
AU - Kelbæk, Henning
AU - Abildgaard, Ulrik
AU - Villadsen, Anton B
AU - Krusell, Lars Romer
AU - Ravkilde, Jan
AU - Hansen, Knud Nørregaard
AU - Christiansen, Evald Høj
AU - Aarøe, Jens
AU - Jensen, Jan Skov
AU - Kristensen, Steen Dalby
AU - Bøtker, Hans Erik
AU - Madsen, Morten
AU - Thayssen, Per
AU - Sørensen, Henrik Toft
AU - Thuesen, Leif
AU - Lassen, Jens Flensted
N1 - Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2012
Y1 - 2012
N2 - This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.
AB - This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.
U2 - 10.1016/j.jcin.2012.04.008
DO - 10.1016/j.jcin.2012.04.008
M3 - Journal article
C2 - 22917452
VL - 5
SP - 812
EP - 818
JO - Circulation: Cardiovascular Interventions
JF - Circulation: Cardiovascular Interventions
SN - 1941-7640
IS - 8
ER -
